Valeria Cancelli
About
Valeria Cancelli is a scholar working on Hematology, Molecular Biology and Genetics.
According to data from OpenAlex, Valeria Cancelli has authored 24 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Valeria Cancelli's work include Acute Myeloid Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and COVID-19 Clinical Research Studies (3 papers). Valeria Cancelli is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and COVID-19 Clinical Research Studies (3 papers). Valeria Cancelli collaborates with scholars based in Italy, United States and Belgium. Valeria Cancelli's co-authors include Giuseppe Rossi, Rossella Ribolla, Chiara Cattaneo, Federica Cattina, Michele Malagola, Angelo Belotti, Simona Bernardi, Alessandra Tucci, Luisa Imberti and Marco Chiarini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
In The Last Decade
Valeria Cancelli
23 papers receiving 199 citations
Peers
Valeria Cancelli
Federica Cocito Italy
Fatima Zahra Jelloul United States
Bhuvan Kishore United Kingdom
Rosane Bittencourt Brazil
Vadim Doronin Russia
Christos Demosthenous Greece
Jiejing Qian China
Lars‐Olof Mügge Germany
Nicole R. Grieselhuber United States
Patric Teodorescu Romania
Citations per year, relative to Valeria Cancelli Valeria Cancelli (= 1×)
peers
Federica Cocito
Countries citing papers authored by Valeria Cancelli
Since
Specialization
Citations
This map shows the geographic impact of Valeria Cancelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Cancelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Cancelli more than expected).
Fields of papers citing papers by Valeria Cancelli
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Valeria Cancelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Cancelli. The network helps show where Valeria Cancelli may publish in the future.
Co-authorship network of co-authors of Valeria Cancelli
This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Cancelli. A scholar is included among the top collaborators of Valeria Cancelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Cancelli. Valeria Cancelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ferraro, Rosalba Monica, Elena Laura Mazzoldi, Mirko Farina, et al.. (2025). Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent. Cell Biology International. 49(5). 570–586.
2.
Fredi, Micaela, Cecilia Nalli, Rossana Orabona, et al.. (2025). Management of Evans’ Syndrome in Pregnancy: A Case Report and a Narrative Review. SHILAP Revista de lepidopterología. 6(1). 6–6.
3.
Cattaneo, Chiara, Valeria Cancelli, Luisa Imberti, et al.. (2021). Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab. Blood Cancer Journal. 11(9). 151–151.
4.
Cattaneo, Chiara, Valeria Cancelli, Chiara Pagani, et al.. (2021). IMPAIRED HUMORAL RESPONSE IN LYMPHOMA PATIENTS SURVIVING THE ACUTE PHASE OF COVID‐19. Hematological Oncology. 39(S2).
5.
Belotti, Angelo, Rossella Ribolla, Marco Chiarini, et al.. (2021). Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT). Blood. 138(Supplement 1). 1641–1641.
6.
Cattaneo, Chiara, Chiara Pagani, Valeria Cancelli, et al.. (2020). Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time. Leukemia. 35(2). 632–634.
7.
Belotti, Angelo, Rossella Ribolla, Valeria Cancelli, et al.. (2020). External Validation of Diffusion Weighted Whole Body MRI (DW-MRI) Response Assessment Category (RAC) Criteria Proposed By the Myeloma Response Assessment and Diagnosis System (MY-RADS) Imaging Recommendations: Prognostic Role of Imaging Response after Transplant in Multiple Myeloma and Comparison with MRD Evaluation By Flow Cytometry. Blood. 136(Supplement 1). 41–42.
8.
Belotti, Angelo, Rossella Ribolla, Valeria Cancelli, et al.. (2020). Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65‐75 years. American Journal of Hematology. 95(7). 759–765.
9.
Malagola, Michele, Nicola Polverelli, Valeria Cancelli, et al.. (2019). Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?. SHILAP Revista de lepidopterología. 2019. 1–4.
10.
Almici, Camillo, Arabella Neva, Cristina Skert, et al.. (2019). Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System. Scientific Reports. 9(1). 87–87.
11.
Belotti, Angelo, Rossella Ribolla, Valeria Cancelli, et al.. (2018). The IMWG Frailty Score and Age Can be More Effective Than Clinical Judgement in the Selection of Elderly Patients with Newly Diagnosed Multiple Myeloma Who Can Benefit from an Intensive Treatment Approach with High Dose Melphalan and Autologous Stem Cell Transplantation. Blood. 132(Supplement 1). 2151–2151.
12.
Skert, Cristina, Marco Chiarini, Viviana Giustini, et al.. (2017). Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation. PLoS ONE. 12(4). e0175337–e0175337.
13.
Malagola, Michele, Federica Cattina, Valeria Cancelli, et al.. (2017). Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line?. Journal of Molecular Biomarkers & Diagnosis. 8(4).
14.
Bernardi, Simona, Michele Malagola, Valeria Cancelli, et al.. (2017). Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML). Journal of Molecular Biomarkers & Diagnosis. 8(3).
15.
Malagola, Michele, Cristina Skert, Erika Borlenghi, et al.. (2015). Postremission sequential monitoring of minimal residual disease by WT 1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients. Cancer Medicine. 5(2). 265–274.
16.
Malagola, Michele, Enrico Morello, Erika Borlenghi, et al.. (2014). WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. Blood. 124(21). 3695–3695.
17.
Skert, Cristina, Manuela Fogli, Emirena Garrafa, et al.. (2014). A specific Toll‐like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation. Transplant Infectious Disease. 16(5). 697–712.
18.
Malagola, Michele, Cristina Skert, Giuseppina Ruggeri, et al.. (2014). Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. BioMed Research International. 2014. 1–5.
19.
Russo, Domenico, Michele Malagola, Carla Filì, et al.. (2013). Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era. Current Cancer Drug Targets. 13(7). 755–767.
20.
Rocchi, Marco, et al.. (1998). Some Unexpected Results in Time Distribution Analysis of Spontaneous Deliveries. Gynecologic and Obstetric Investigation. 46(2). 88–90.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Federica Cocito Breakdown of academic impact, for papers by Fatima Zahra Jelloul Breakdown of academic impact, for papers by Bhuvan Kishore Breakdown of academic impact, for papers by Rosane Bittencourt Breakdown of academic impact, for papers by Vadim Doronin Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Jiejing Qian Breakdown of academic impact, for papers by Lars‐Olof Mügge Breakdown of academic impact, for papers by Nicole R. Grieselhuber Breakdown of academic impact, for papers by Patric Teodorescu